|
1. Dowman B, Campbell RM, Zgaga L, Adeloye D, Chan KY. Estimating the burden of rheumatoid arthritis in Africa: A systematic analysis. J Glob Health. 2012 Dec; 2(2): 020406. doi: 10.7189/jogh.02.020406 2. Goldblatt F, Isenberg DA. New therapies for rheumatoid arthritis. Clin Exp Immunol. 2005 May; 140(2): 195-204. doi: 10.1111/j.1365-2249.2005.02744.x 3. Edwards CJ, Cooper C. Early environmental factors and rheumatoid arthritis. Clin Exp Immunol. 2006 Jan; 143(1): 1-5. doi: 10.1111/j.1365-2249.2005.02940.x 4. Molina V, Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity. 2005 May; 38(3): 235-45. doi: 10.1080/08916930500050277 5. Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009 Jun; 60(6): 1647-56. doi: 10.1002/art.24568 6. Waite JC, Skokos D. Th17 response and inflammatory autoimmune diseases. Int J Inflam. Volume 2012, Article ID 819467. http://dx.doi.org/10.1155/2012/819467 7. McGuirk P, Mills KH. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol. 2002 Sep; 23(9): 450-55. 8. Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol. 2002 Jun; 2(6): 389-400. doi: 10.1038/nri821 9. Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol. 2007 Mar; 8(3): 277-84. doi: 10.1038/ni1437 10. Pillai V, Karandikar NJ. Human regulatory T cells: a unique, stable thymic subset or a reversible peripheral state of differentiation? Immunol Lett. 2007 Nov; 114(1): 9-15. doi: 10.1016/j.imlet.2007.08.012 11. Lozano T, Casares N, Lasarte JJ. Searching for the Achilles Heel of FOXP3. Front Oncol. 2013 Dec; 3: 294. doi: 10.3389/fonc.2013.00294 12. Paradowska-Gorycka A, Jurkowska M, Felis-Giemza A, Romanowska-Próchnicka K, Manczak M, Maslinski S, et al. Genetic polymorphisms of Foxp3 in patients with rheumatoid arthritis. J Rheumatol. 2015 Feb; 42(2): 170-80. doi: 10.3899/jrheum.131381 13. Naderi-Mahabadi F, Zarei S, Fatemi R, Kamali K, Pahlavanzadeh Z, Jeddi-Tehrani M, et al. Association study of forkhead box P3 gene polymorphisms with unexplained recurrent spontaneous abortion. J Reprod Immunol. 2015 Aug; 110: 48-53. doi: 10.1016/j.jri.2015.04.001 14. Hashemi V, Farrokhi AS, Tanomand A, Babaloo Z, Hojjat-Farsangi M, Anvari E, et al. Polymorphism of Foxp3 gene affects the frequency of regulatory T cells and disease activity in patients with rheumatoid arthritis in Iranian population. Immunol Lett. 2018 Dec; 204: 16-22. doi: 10.1016/j.imlet.2018.10.001 15. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb; 16(3): 1215. 16. Lin SC, Chen KH, Lin CH, Kuo CC, Ling QD, Chan CH. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest. 2007 Dec; 37(12): 987-96. doi: 10.1111/j.1365-2362.2007.01882.x 17. Rahnama R, Mansouri R, Valizadeh H, Rahimdel A, Eslami G. [Investigating Prevalence of FOXP3 Gene Polymorphism in Multiple Sclerosis]. J Shahid Sadoughi Uni Med Sci. 2015; 22(6): 1604-11. [Article in Persian] 18. Bahadivand Chegini H, Pourgheysari B, Pourahmadiyan A, Kazemi S, Shirzad H, Mosavi M, et al. [Association between rs56066773 and rs56232250 polymorphisms of FOXP3 gene in target site of microRNA with rheumatoid arthritis in patients referred to Emam Ali clinic of Shahrekord]. J Shahrekord Univ Med Sci. 2016; 18(1): 9-17. [Article in Persian] 19. Mahdavi R, Jamali M, Rostami M, Safa A, Jafarzadeh A, Naseri M. [FOXP3 polymorphism rs2232365 and its association with multiple sclerosis susceptibility]. Tehran Univ Med J. 2016; 74(6): 425-32. [Article in Persian] 20. Jafarzadeh A, Mahdavi R, Jamali M, Hajghani H, Nemati M, Ebrahimi HA. Increased Concentrations of Interleukin-33 in the Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis. Oman Med J. 2016 Jan; 31(1): 40-45. doi: 10.5001/omj.2016.08
|
